ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - interferon alfa 2a 4.5 miu / 0.5 ml - solution for injection - interferon alfa-2a - roferon-a is indicated for the treatment of:- condylomata acuminata - hairy cell leukaemia.- aids patients with progressive, asymptomatic kaposi's sarcoma who have a cd4 count > 250/mm3.- chronic phase philadelphia-chromosome positive chronic myelogenous leukaemia. roferon-a is not an alternative treatment for cml patients who have an hla-identical relative and for whom allogeneic bone marrow transplantation is planned or possible in the immediate future. it is still unknown whether roferon-a can be considered as a treatment with a curative potential in this indication.- adult patients with histologically proven chronic hepatitis b who have markers for viral replication, i.e., those who are positive for hbv dna or hbeag.- adult patients with histologically proven chronic hepatitis c who are positive for hcv antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation.- follicular non-hodgkin’s lymphoma.- advanced renal cell carcinoma.- patients with ajcc stage ii m

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - interferon alfa 2a 6 miu / 0.5 ml - solution for injection - interferon alfa-2a - roferon-a is indicated for the treatment of:- condylomata acuminata - hairy cell leukaemia.- aids patients with progressive, asymptomatic kaposi's sarcoma who have a cd4 count > 250/mm3.- chronic phase philadelphia-chromosome positive chronic myelogenous leukaemia. roferon-a is not an alternative treatment for cml patients who have an hla-identical relative and for whom allogeneic bone marrow transplantation is planned or possible in the immediate future. it is still unknown whether roferon-a can be considered as a treatment with a curative potential in this indication.- adult patients with histologically proven chronic hepatitis b who have markers for viral replication, i.e., those who are positive for hbv dna or hbeag.- adult patients with histologically proven chronic hepatitis c who are positive for hcv antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation.- follicular non-hodgkin’s lymphoma.- advanced renal cell carcinoma.- patients with ajcc stage ii m

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - interferon alfa 2a 9 miu / 0.5 ml - solution for injection - interferon alfa-2a - roferon-a is indicated for the treatment of:- condylomata acuminata - hairy cell leukaemia.- aids patients with progressive, asymptomatic kaposi's sarcoma who have a cd4 count > 250/mm3.- chronic phase philadelphia-chromosome positive chronic myelogenous leukaemia. roferon-a is not an alternative treatment for cml patients who have an hla-identical relative and for whom allogeneic bone marrow transplantation is planned or possible in the immediate future. it is still unknown whether roferon-a can be considered as a treatment with a curative potential in this indication.- adult patients with histologically proven chronic hepatitis b who have markers for viral replication, i.e., those who are positive for hbv dna or hbeag.- adult patients with histologically proven chronic hepatitis c who are positive for hcv antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation.- follicular non-hodgkin’s lymphoma.- advanced renal cell carcinoma.- patients with ajcc stage ii m

ישראל - עברית - Ministry of Health

syneron medical - אחר - מכשיר להסרת שיער המבוסס על שילוב של שני סוגי אנרגיה : אנרגית אור ואנרגית fr המגיעות לעור בו זמנית ע'י ידית הטיפולים.

ישראל - עברית - Ministry of Health

syneron medical - אחר - non-invasive treatment for body contouring via temporary cellulite and circumference reduction.

ישראל - עברית - Ministry of Health

syneron medical - אחר - "non-invasive treatment system of temporarily reduction of cellulite, non-invasive body contouring via temporary circumferences reduction "

ישראל - עברית - Ministry of Health

syneron medical - אחר - the eprime system is indicated for use in dermatologic and esthetic procedures for electrocoagulation and the percutaneous treatment of facial wrinkles.

ישראל - עברית - Ministry of Health

syneron medical - רופא - "the lipolite system is intended for dermatological procedures requiring incision, excision, vaporization, ablation and coagulation of soft tissue. the lipolite system is further indicated for laser-assisted lipolysis."

ישראל - עברית - Ministry of Health

syneron medical - אחר - "the co2re system is indicated for use in the performance of dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin."

ישראל - עברית - Ministry of Health

syneron medical - רופא - the lipolite system is intended for dermatological procedures requiring incision, excision, vaporization, ablation and coagulation of soft tissue. the lipolite system is further indicated for laser-assisted lipolysis.